The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies
Vanessa Chenel,1–4 Patrick Boissy,1–3 Marie-Sol Poirier,1–3 Jean-Pierre Cloarec,3,4 Johane Patenaude1–3 1Interdisciplinary Institute for Technological Innovation (3IT), 2Department of Surgery, Faculty of Medicine and Health Sciences, Université de...
Guardado en:
Autores principales: | Chenel V, Boissy P, Poirier MS, Cloarec JP, Patenaude J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be5d1db65cd54b18a5134c048fb22a1c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetically engineered nanocarriers for drug delivery
por: Shi P, et al.
Publicado: (2014) -
Advances in nanocarriers as drug delivery systems in Chagas disease
por: Quijia Quezada C, et al.
Publicado: (2019) - Research & Reports in Transdermal Drug Delivery
-
Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery
por: He P, et al.
Publicado: (2021) -
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
por: Edis Z, et al.
Publicado: (2021)